Brian Armstrong Will Sell 2% Of His Coinbase Holdings To Fund Scientific Research

It’s time for Brian Armstrong to make his move. The Coinbase CEO is not like other billionaire CEOs who try to purchase bankrupt cryptocurrency companies cheaply. He’s concentrating his efforts on science and hard science. To announce his new endeavors Brian Armstrong visited Tim Ferriss’ podcast. In that interview, he expanded on the deep topics that the companies he’ll fund deal with. However, this is not the real announcement. Brian Armstrong was selling Coinbase stock.

In a recent Twitter thread, the Coinbase CEO wrote, “I’m passionate about accelerating science and tech to help solve some of the biggest challenges in the world. To further this, I’m planning to sell about 2% of my Coinbase holdings over the next year to fund scientific research and companies like NewLimit + ResearchHub.” What are those companies and what do they do? Continue reading to learn more.

Considering the alarming amount of crypto CEOs leaving their positions, it’s important that Brian Armstrong cleared this up. “For the avoidance of doubt, I intend to be CEO of Coinbase for a very long time and I remain super bullish on crypto and Coinbase. I’m fully dedicated to growing our business and advancing our mission, but I am also excited to contribute in a different way,” he tweeted.

Brian Armstrong is so excited about these ideas. Let’s find out.

Brian Armstrong ’s ResearchHub And NewLimit

So, Brian Armstrong will “fund scientific research and companies like NewLimit + ResearchHub.” What do those companies stand for, though? Well, ResearchHub is “a  tool for the open publication and discussion of scientific research. Researchhub’s users are rewarded with ResearchCoin (RSC) for publishing, reviewing, criticizing, and collaborating in the open.” Interesting, an open think tank with a cryptocurrency component.

ResearchCoin, for its part is both a utility token as well as a governance token. “RSC gives users the ability to create bounties, tip other users, and gain voting rights within community decision making.” This is their Twitter account.

However, NewLimit can be found here “treating age-related disease to extend human healthspan” and “developing epigenetic reprogramming medicines to treat diseases with large unmet needs.” This is their Twitter account. The details of this business are difficult to comprehend. NewLimit has the solution. a blog postBrian Armstrong has written this book, and he dives deep into the subject matter.

“NewLimit will start by deeply interrogating epigenetic drivers of aging and developing products that can regenerate tissues to treat specific patient populations. We will start by using primary human cells and reference species to develop machine learning models on what chromatin features change with age, which of these changes may be causal to the aging process, and finally develop therapies that could slow, halt, or reverse this process.”

In that same blog post, we learn that the company was “co-founded by Brian Armstrong and Blake Byers with the mission of extending human healthspan.” And thus, we figure out that Coinbase CEO is the money behind both companies.

COINUSDT price chart - TradingView

 Source : COIN/USDT at TradingView.com| Source: COIN/USDT on TradingView.com

Interview with Tim Ferriss

Brian Armstrong was determined to launch his new ventures the right way. The popular podcast by Tim Ferriss. He explained the reasons behind his investment in it. “I think we’re kind of in this golden age of software where fortunes are being made. But some of that wealth, even in crypto, is now being directed into hard science, hard science problems, atoms, not bits,” he said.

As to what the company actually does, Armstrong explained that they’re trying to “build a platform that tests a lot of different transcription factors with different cell types and uses machine learning to do that in a virtuous cycle.” He also explained the entrepreneurial spirit behind the whole ordeal.

“We’re trying to help humans live much longer, not just a little bit longer. However, I believe that any moonshot company should have intermediate milestones. And so the intermediate milestones are more like, could we get a specific type of cell to be rejuvenated and be younger?”

About ResearchHub, the Coinbase CEO confirmed that it is “another company that I funded and tried to help get off the ground.” What does this one do? 

“We’re trying to make it easy for people to sort through all of the millions of papers that are published every year to what are the most impactful. We’re trying to help get things like peer review, Q&A, comments, feedback around research to be more collaborative with people.”

And these are the things Brian Armstrong intends to devote the rest of his adult life. While at the same time serving as Coinbase’s CEO, of course.

Featured Image: Screenshot of this video Charts by TradingView| Charts by TradingView

Get more Crypto News at CFX Magazine